Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies.
about
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase I clinical trial of the ...... nced hematologic malignancies.
@en
Phase I clinical trial of the ...... nced hematologic malignancies.
@nl
type
label
Phase I clinical trial of the ...... nced hematologic malignancies.
@en
Phase I clinical trial of the ...... nced hematologic malignancies.
@nl
prefLabel
Phase I clinical trial of the ...... nced hematologic malignancies.
@en
Phase I clinical trial of the ...... nced hematologic malignancies.
@nl
P2093
P2860
P356
P1433
P1476
Phase I clinical trial of the ...... nced hematologic malignancies.
@en
P2093
Afshin Dowlati
Basem M William
Brenda W Cooper
Marcos de Lima
Paolo F Caimi
Paul M Barr
Stanton L Gerson
P2860
P304
79864-79875
P356
10.18632/ONCOTARGET.20094
P407
P577
2017-08-09T00:00:00Z